To evaluate further the evidence for an association between AR CAG repeat length and breast cancer risk in BRCA1 and BRCA2 mutation carriers, we genotyped the polymorphism in a large series of female mutation carriers. The gene discussed is BRCA1; the disease is breast cancer.